- Home
- WOLF vs ALVO Comparison
WOLF vs ALVO Comparison
Compare WOLF & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WOLF | ALVO |
|---|---|---|
| Founded | 1987 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | 1460 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | WOLF | ALVO |
|---|---|---|
| Price | $32.82 | $3.81 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $14.33 | $8.00 |
| AVG Volume (30 Days) | ★ 3.7M | 785.0K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,385,982,000.00 | N/A |
| Revenue This Year | N/A | $13.28 |
| Revenue Next Year | $7.43 | $18.63 |
| P/E Ratio | ★ N/A | $18.20 |
| Revenue Growth | ★ 19.00 | N/A |
| 52 Week Low | $1.16 | $2.94 |
| 52 Week High | $80.82 | $9.25 |
Technical Indicators
Market Signals| Indicator | WOLF | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | 57.03 |
| Support Level | $15.86 | $3.10 |
| Resistance Level | $31.99 | $4.02 |
| Average True Range (ATR) | 2.43 | 0.23 |
| MACD | 0.83 | 0.07 |
| Stochastic Oscillator | 63.12 | 70.37 |
Price Performance
Historical ComparisonAbout WOLF Wolfspeed Inc.
Wolfspeed Inc develops and manufactures semiconductor technologies based on silicon carbide (SiC) for power electronics applications. Its product portfolio includes SiC MOSFETs, Schottky diodes, and power modules used in power electronics applications. The company also provides reference designs, evaluation kits, and gate driver boards to support the development and integration of its SiC products across industries such as electric vehicles, renewable energy, and industrial systems.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.